Kardigan, Inc. (KARD)

21.92 +2.32 (+11.84%) USD  |  NASDAQ  |  Sep 02, 16:00
21.88 -0.04 (-0.18%) After-Hours: 20:00
More

Kardigan Shareholders Equity (Quarterly) : 615.52M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for KARD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 615.52M
Date Value
March 31, 2026 296.92M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Johnson & Johnson 84.97B
Bristol Myers Squibb Co. 22.32B
Crinetics Pharmaceuticals, Inc. 1.192B
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 721.79M
Total Liabilities (Quarterly) 106.26M
Debt to Equity Ratio 0.0217
Current Ratio 8.716
Net Debt Paydown Yield -0.10%